161 related articles for article (PubMed ID: 38282073)
21. Embryonal precursors of Wilms tumor.
Coorens THH; Treger TD; Al-Saadi R; Moore L; Tran MGB; Mitchell TJ; Tugnait S; Thevanesan C; Young MD; Oliver TRW; Oostveen M; Collord G; Tarpey PS; Cagan A; Hooks Y; Brougham M; Reynolds BC; Barone G; Anderson J; Jorgensen M; Burke GAA; Visser J; Nicholson JC; Smeulders N; Mushtaq I; Stewart GD; Campbell PJ; Wedge DC; Martincorena I; Rampling D; Hook L; Warren AY; Coleman N; Chowdhury T; Sebire N; Drost J; Saeb-Parsy K; Stratton MR; Straathof K; Pritchard-Jones K; Behjati S
Science; 2019 Dec; 366(6470):1247-1251. PubMed ID: 31806814
[TBL] [Abstract][Full Text] [Related]
22. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
Rivera MN; Haber DA
Nat Rev Cancer; 2005 Sep; 5(9):699-712. PubMed ID: 16110318
[TBL] [Abstract][Full Text] [Related]
23. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
24. Expression of insulin-like growth factor-II transcripts in Wilms' tumour.
Reeve AE; Eccles MR; Wilkins RJ; Bell GI; Millow LJ
Nature; 1985 Sep 19-25; 317(6034):258-60. PubMed ID: 2995817
[TBL] [Abstract][Full Text] [Related]
25. The WTX Tumor Suppressor Interacts with the Transcriptional Corepressor TRIM28.
Kim WJ; Wittner BS; Amzallag A; Brannigan BW; Ting DT; Ramaswamy S; Maheswaran S; Haber DA
J Biol Chem; 2015 Jun; 290(23):14381-90. PubMed ID: 25882849
[TBL] [Abstract][Full Text] [Related]
26. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
27. A new precursor lesion of Wilms' tumour (nephroblastoma): intralobar multifocal nephroblastomatosis.
Machin GA; McCaughey WT
Histopathology; 1984 Jan; 8(1):35-53. PubMed ID: 6323299
[TBL] [Abstract][Full Text] [Related]
28. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.
Slade I; Stephens P; Douglas J; Barker K; Stebbings L; Abbaszadeh F; Pritchard-Jones K; ; Cole R; Pizer B; Stiller C; Vujanic G; Scott RH; Stratton MR; Rahman N
J Med Genet; 2010 May; 47(5):342-7. PubMed ID: 19948536
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
30. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.
Scott RH; Stiller CA; Walker L; Rahman N
J Med Genet; 2006 Sep; 43(9):705-15. PubMed ID: 16690728
[TBL] [Abstract][Full Text] [Related]
31. Paternally inherited WT1 mutation plus uniparental disomy of 11p may be an essential mechanism for development of WT1-mutated familial Wilms tumor.
Sato Y; Haruta M; Kaneko Y; Nakasato Y; Kurosawa H; Yoshihara S
Pediatr Blood Cancer; 2019 Jan; 66(1):e27442. PubMed ID: 30221469
[No Abstract] [Full Text] [Related]
32. Cytogenetic abnormalities in mesoblastic nephroma: a link to Wilms' tumour?
Roberts P; Lockwood LR; Lewis IJ; Bailey CC; Batcup G; Williams J
Med Pediatr Oncol; 1993; 21(6):416-20. PubMed ID: 8390601
[TBL] [Abstract][Full Text] [Related]
33. Correlations between histological characterizations and methylation statuses of tumour suppressor genes in Wilms' tumours.
Lai YC; Lu MY; Wang WC; Hou TC; Kuo CY
Int J Exp Pathol; 2022 Jun; 103(3):121-128. PubMed ID: 35436013
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetic findings in Wilms' tumour: a single institute study.
MdZin R; Murch A; Charles A
Pathology; 2010 Dec; 42(7):643-9. PubMed ID: 21080873
[TBL] [Abstract][Full Text] [Related]
35. Methylation Statuses of H19DMR and KvDMR at WT2 in Wilms Tumors in Taiwan.
Lu MY; Wang WC; Hou TC; Kuo CY; Lai YC
Pathol Oncol Res; 2020 Oct; 26(4):2153-2159. PubMed ID: 32157637
[TBL] [Abstract][Full Text] [Related]
36. Teratoid Wilms Tumor: Report of Three Cases and Review of the Literature.
Ghamdi DA; Bakshi N; Akhtar M
Turk Patoloji Derg; 2019; 35(1):61-68. PubMed ID: 28272669
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
Cheah PL; Looi LM; Chan LL
Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
[TBL] [Abstract][Full Text] [Related]
38. Role of the WT1 gene in Wilms' tumour.
Haber DA; Housman DE
Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic problems in a Wilms' tumour of the horseshoe kidney.
Beseghi U; Del Rossi C; Cerasoli G; Miselli A; Ghinelli C
Z Kinderchir; 1988 Apr; 43(2):110-1. PubMed ID: 2838988
[TBL] [Abstract][Full Text] [Related]
40. Metastasizing rat nephroblastoma. A rodent Wilms' tumour model.
Rásó E; Timár J; Paku S; Lapis K
Carcinogenesis; 1994 Jun; 15(6):1243-9. PubMed ID: 8020162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
